|
MGX Metagenomi Therapeutics Inc 1785279 |
| Balance Sheet |
|
Current Assets
|
$144,558,000.00 |
|
Assets
|
$196,953,000.00 |
|
Current Liabilities
|
$22,499,000.00 |
|
Liabilities
|
$59,168,000.00 |
|
Equity
|
$137,785,000.00 |
|
Shares Out
|
37647057.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,175,000.00 |
|
Investing Cash Flow
|
$3,986,000.00 |
| Market Analysis |
Market Cap
|
$45,929,409.54 |
|
Price
|
$1.21 |
|
BVPS
|
3.66 |
|
PB
|
0.33 |
|
EPS
|
-0.61 |
|
PS
|
9.50 |
|
FCF
|
$-21,200,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:40 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MGX documents filed with the SEC.
MGX Filings
Clear
